Company Overview - Pfizer's stock has seen a significant decline, down 59% from its all-time high of $61.71 in 2021, currently struggling to maintain levels above $20 [2] - The company has a market capitalization of $144 billion [3] Options Activity - On March 20, Pfizer's $29 put option exhibited the highest unusual options activity with a Vol/OI ratio of 210.16, indicating a volume of 30,263 against an open interest of 144 [1][3] - The options activity suggests that there is significant interest in the stock, with the March 20 $29 call option also showing similar volume, indicating a potential Long Straddle strategy [5] Historical Context - Pfizer's 30-day average options volume is 142,695, with the recent activity being 1.39 times that amount, marking the highest volume since December 17 [6] - The highest options volume in the past three months reached 890,898, occurring shortly after the company reported its Q3 2025 results on November 4 [7] Earnings Guidance - Pfizer reaffirmed its 2025 guidance on December 16, projecting adjusted earnings per share of $2.90 at the midpoint, a decrease from $3.08 in 2025 [8]